MacuMira

11/14/2025

On World Diabetes Day, we're committed to protecting vision from every angle.

People with diabetes face multiple retinal risks beyond diabetic eye disease.

MacuMira provides a safe, non-invasive option for dry AMD care alongside diabetic eye management, thereby helping to ensure retinal protection.

https://macumira.com/

11/13/2025

👁️ Discover the future of Dry AMD treatment at Ranzco this week!

MacuMira is the first-and-only microcurrent treatment for Dry AMD in and , and it’s making its debut at the Melbourne Convention and Exhibition Centre this Friday 14th November!

This non-invasive treatment requires no injections or systemic drugs. Instead, the device uses Microcurrent Stimulation (MCS) to stimulate the mitochondria, boosting ATP production for healthier retinal cells*

Seamlessly integrating into your workflow, the wearable class II medical headset delivers MCS through closed eyelids, supporting retinal cell function and mitochondrial activity with:

*A loading phase of 4 x 32-minute sessions
*One maintenance treatment every 2–3 months to sustain results

📍Visit stand #152 and #66 to visit MacuMira and our exclusive distributor, ParagonCare, to demo the MacuMira device or learn more at: www.keelerglobal.com/macumira/?utm_campaign=macumira&utm_source=organic&utm_medium=social-t…



*Sehic A, Guo S, Cho KS, Corraya RM, Chen DF, Utheim, TP. Electrical Stimulation as a Means for Improving Vision. 2016 Nov, 186 (11)

11/08/2025

Each year, the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) hosts the region’s leading ophthalmology congress, bringing together clinicians, researchers, and innovators shaping the future of vision care.

MacuMira is proud to join this year’s event alongside our distribution partner, Keeler.

📍 Visit us at the Melbourne Convention & Exhibition Centre, November 14-17.

Be among the first to experience this breakthrough technology and schedule your demo via the link in bio.

Non-invasive, TGA and Medsafe-approved, and easy to administer, MacuMira delivers evidence-based results that elevate both practice and patient outcomes.

https://macumira.com/

11/06/2025

Put progress in the hands of your patients and your practice.

Dry AMD care is evolving rapidly. With MacuMira, your clinic can help lead the way. Our device is a non-pharmacologic solution that empowers patients while delivering life-changing outcomes backed by science.

https://macumira.com/

11/04/2025

We’re on CityNews - Calgary tonight!

See how and MacuMira are working together to help patients with dry AMD protect and restore their vision. 👁️

11/04/2025

This Diabetic Eye Disease Awareness Month, remember: diabetic eye disease is a leading cause of vision loss, but it's not the only threat.

Dry AMD can progress silently alongside diabetic complications. Comprehensive eye care means addressing the full picture of retinal health, not just 1 condition at a time.

https://macumira.com/

10/30/2025

These are the stories that matter.

Ingrid’s journey is why we do what we do. 💙

10/30/2025

/CNW/ - Keeler, a global leader in ophthalmic innovation with more than a century of heritage, and MacuMira Medical Devices Inc, a pioneering Canadian company,...

10/30/2025

The newly approved technology delivers low-dose microcurrents through closed eyelids to stimulate retinal cells.

10/30/2025

Give your dry AMD patients more than a diagnosis.

Too often, patients hear "come back in 6 months" with no path forward.

MacuMira helps transform that conversation by offering active support that promotes retinal health, functional vision, and genuine peace of mind.

Your patients deserve action, not just observation.

https://macumira.com/

10/28/2025

Help your patients stay independent longer, and offer them a solution that preserves both their sight and their freedom.

Dry AMD affects more than just vision. It also impacts quality of life. MacuMira supports your patients’ independence with a safe, effective, in-office treatment that requires no injections or surgery.

https://macumira.com/

10/23/2025

Dry AMD deserves proactive solutions, not passive monitoring.

Traditional approaches are frustrating. MacuMira transforms care with an effective and non-invasive therapy that supports visual function and restores patient confidence without adding clinical burden to your practice.

https://macumira.com/

MacuMira is clinically proven to improve the visual function in patients with dry AMD. Learn how this noninvasive therapy can help & find a provider near you.